Table 2.
Laboratory results.
| Parameter | Subjects with Hepatocellular Carcinoma | Subjects without Hepatocellular Carcinoma | p-Value |
|---|---|---|---|
| n = 95 | n = 59 | ||
| CK-19 (ng/mL) | 1.26 [0.13–41.91] | 1.43 [0.16–6.43] | 0.076 |
| AFP (ng/mL) | 134.62 [2.5–1420.0] | 2.47 [0.25–32.96] | <0.001 |
| AFP_L3 (ng/mL) | 14.28 [0.33–98.1] | 0.98 [0.09–30.27] | <0.001 |
| DCP (ng/mL) | 3.12 [0.46–1061] | 0.25 [0.10–0.95] | <0.001 |
| Glypican (pg/mL) | 423.59 [129.48–10,032.18] | 270.81 [29.75–699.96] | <0.001 |
| Serum albumin (g/dL) | 3 [1.2–4.3] | 2.3 [1.3–3.4] | <0.001 |
| ALT (UI/L) | 55 [6–419] | 32 [12–444] | <0.001 |
| AST (UI/L) | 74 [20–687] | 71 [36–1186] | 0.445 |
| TB (mg/dL) | 1.42 [0.40–16.3] | 3.4 [0.2–28] | <0.001 |
| DB (mg/dL) | 0.54 [0.05–13.5] | 2.08 [0.13–18.6] | <0.001 |
| ALP (UI/L) | 117 [36–897] | 118 [35–360] | 0.996 |
| GGT (UI/L) | 100 [14–1363] | 138 [28–1156] | 0.594 |
| Platelet count | 121,000 [40,000–590,000] | 129,000 [36,000–351,900] | 0.872 |
n—number; CK-19—cytokeratin 19; AFP—alpha-fetoprotein; AFP_L3—alpha-fetoprotein L3; DCP—des-g-carboxyprothrombin; ALT—alanine aminotransferase; AST—aspartate aminotransferase; TB—total bilirubin; DB—direct bilirubin; ALP—alkaline phosphatase; GGT—gamma glutamyl transferase.